Sangro B, Melero I, Yau T, et al. Nivolumab in Sorafenib-Naive and -Experienced Patients With Advanced Hepatocellular Carcinoma (HCC): Survival, Hepatic Safety, and Biomarker Assessments in CheckMate 040. AAASLD 2017, Presidential Poster of Distinction 141.
Vaker remissie met MMF versus azathioprine als eerstelijnstherapie auto-immuunhepatitis
mei 2024 | Hepatitis, Hepatologie